
Neurones SA
PAR:NRO

Neurones SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
40.25
51.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Neurones SA hold over its rivals?
What risks and challenges
does Neurones SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Neurones SA.
Provide an overview of the primary business activities
of Neurones SA.
What unique competitive advantages
does Neurones SA hold over its rivals?
What risks and challenges
does Neurones SA face in the near future?
Has there been any significant insider trading activity
in Neurones SA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Neurones SA.
Provide P/S
for Neurones SA.
Provide P/E
for Neurones SA.
Provide P/OCF
for Neurones SA.
Provide P/FCFE
for Neurones SA.
Provide P/B
for Neurones SA.
Provide EV/S
for Neurones SA.
Provide EV/GP
for Neurones SA.
Provide EV/EBITDA
for Neurones SA.
Provide EV/EBIT
for Neurones SA.
Provide EV/OCF
for Neurones SA.
Provide EV/FCFF
for Neurones SA.
Provide EV/IC
for Neurones SA.
Show me price targets
for Neurones SA made by professional analysts.
What are the Revenue projections
for Neurones SA?
How accurate were the past Revenue estimates
for Neurones SA?
What are the Net Income projections
for Neurones SA?
How accurate were the past Net Income estimates
for Neurones SA?
What are the EPS projections
for Neurones SA?
How accurate were the past EPS estimates
for Neurones SA?
What are the EBIT projections
for Neurones SA?
How accurate were the past EBIT estimates
for Neurones SA?
Compare the revenue forecasts
for Neurones SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Neurones SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Neurones SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Neurones SA compared to its peers.
Compare the P/E ratios
of Neurones SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Neurones SA with its peers.
Analyze the financial leverage
of Neurones SA compared to its main competitors.
Show all profitability ratios
for Neurones SA.
Provide ROE
for Neurones SA.
Provide ROA
for Neurones SA.
Provide ROIC
for Neurones SA.
Provide ROCE
for Neurones SA.
Provide Gross Margin
for Neurones SA.
Provide Operating Margin
for Neurones SA.
Provide Net Margin
for Neurones SA.
Provide FCF Margin
for Neurones SA.
Show all solvency ratios
for Neurones SA.
Provide D/E Ratio
for Neurones SA.
Provide D/A Ratio
for Neurones SA.
Provide Interest Coverage Ratio
for Neurones SA.
Provide Altman Z-Score Ratio
for Neurones SA.
Provide Quick Ratio
for Neurones SA.
Provide Current Ratio
for Neurones SA.
Provide Cash Ratio
for Neurones SA.
What is the historical Revenue growth
over the last 5 years for Neurones SA?
What is the historical Net Income growth
over the last 5 years for Neurones SA?
What is the current Free Cash Flow
of Neurones SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Neurones SA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
FR |
![]() |
Neurones SA
PAR:NRO
|
1.2B EUR | 1.5 | |
US |
![]() |
International Business Machines Corp
NYSE:IBM
|
222.5B USD | 3.5 |
|
IE |
![]() |
Accenture PLC
NYSE:ACN
|
185.8B USD | 2.8 |
|
IN |
![]() |
Tata Consultancy Services Ltd
NSE:TCS
|
12.5T INR | 4.9 |
|
IN |
![]() |
Infosys Ltd
NSE:INFY
|
6.2T INR | 3.8 |
|
IN |
![]() |
HCL Technologies Ltd
NSE:HCLTECH
|
4.3T INR | 3.6 |
|
JP |
![]() |
Fujitsu Ltd
TSE:6702
|
5.6T JPY | 1.6 |
|
US |
![]() |
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
36.1B USD | 1.8 |
|
JP |
![]() |
NEC Corp
TSE:6701
|
4.6T JPY | 1.4 |
|
US |
![]() |
Gartner Inc
NYSE:IT
|
32.3B USD | 5.2 |
|
IN |
![]() |
Wipro Ltd
NSE:WIPRO
|
2.5T INR | 2.8 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
FR |
![]() |
Neurones SA
PAR:NRO
|
Average P/S:
3
1.5
|
N/A | N/A | |
US |
![]() |
International Business Machines Corp
NYSE:IBM
|
3.5
|
5%
|
0.7 |
|
IE |
![]() |
Accenture PLC
NYSE:ACN
|
2.8
|
7%
|
0.4 |
|
IN |
![]() |
Tata Consultancy Services Ltd
NSE:TCS
|
4.9
|
7%
|
0.7 |
|
IN |
![]() |
Infosys Ltd
NSE:INFY
|
3.8
|
7%
|
0.5 |
|
IN |
![]() |
HCL Technologies Ltd
NSE:HCLTECH
|
3.6
|
8%
|
0.5 |
|
JP |
![]() |
Fujitsu Ltd
TSE:6702
|
1.6
|
N/A | N/A |
|
US |
![]() |
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
1.8
|
6%
|
0.3 |
|
JP |
![]() |
NEC Corp
TSE:6701
|
1.4
|
3%
|
0.5 |
|
US |
![]() |
Gartner Inc
NYSE:IT
|
5.2
|
8%
|
0.6 |
|
IN |
![]() |
Wipro Ltd
NSE:WIPRO
|
2.8
|
4%
|
0.7 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.